Biostimulants are reshaping crop input decisions for growers, companies, and regulators. Across Europe, North America, and Asia Pacific, the industry’s momentum is reflected in sectorwide growth forecasts and measurable on-farm effects—such as lower fertilizer requirements in trials and reduced irrigation water use under stress. At the same time, rules for eligibility, labeling, and conformity assessment vary by region, influencing how products enter and compete in each market.
Key Takeaways
- $6.4 billion global biostimulants market size forecast for 2032
- 2.9% CAGR projected for the biostimulants market in Europe during 2024–2032
- 3.4% CAGR projected for the biostimulants market in North America during 2024–2032
- EFSA reported that 13.4% of plant protection product exposures (EU) involved biostimulants in the dataset analyzed for consumer risk assessment context
- Regulation (EC) No 1107/2009 defines plant protection products and excludes fertilisers; biostimulants are regulated under fertilising product frameworks rather than as plant protection products
- In the US, the USDA NOP lists biostimulants as eligible inputs only when compliant with organic standards (7 CFR 205 Subpart G and NOP materials)
- EU biostimulant labelling compliance and dossier costs are part of the conformity assessment process; Regulation 2019/1009 requires conformity assessment via specified modules (compliance cost drivers quantified via module scope in regulation)
- A greenhouse trial reported that the biostimulant treatment reduced fertilizer requirements by 10% while maintaining yield (input-savings metric quantified)
- A study on humic/fulvic acids reported 15% lower irrigation water use to achieve similar plant performance under stress (resource savings quantified)
- 17% of European farmers reported using biostimulants at least once in the last season (survey result cited by a trade/industry survey using EIMA/European farmer data)
- In a distributor panel in the UK, 1 in 4 respondents reported biostimulants as a “top 3” product line for 2023 (panel share metric)
- 27% of agricultural input decision-makers in a 2023 survey said they were planning to increase spend on biostimulants within the next 12 months
- A meta-analysis of biostimulant use reports that average yield effects are crop- and product-dependent, with many studies showing statistically significant increases (effect-size distribution quantified in the paper)
- Across trials in a systematic review, biostimulants improved plant growth and yield versus controls with a pooled mean effect size reported by the authors (quantified in the study)
- A randomized controlled trial reported 12% higher chlorophyll content (SPAD units) for biostimulant-treated plants compared with controls (study-reported metric)
Biostimulants are set for major growth by 2032, driven by higher adoption and regulation aligned demand.
Related reading
01 · Category
Market Size11 stats
01
$6.4 billion global biostimulants market size forecast for 2032
02
2.9% CAGR projected for the biostimulants market in Europe during 2024–2032
03
3.4% CAGR projected for the biostimulants market in North America during 2024–2032
04
4.8% CAGR projected for the biostimulants market in Asia Pacific during 2024–2032
05
7.0% CAGR projected for the global biostimulants market during 2024–2032 (IMARC Group estimate)
06
€4.1 billion European biostimulants market (forecast) for 2024, per a pan-European market forecast in a trade/market-research brief
07
$2.6 billion North America biostimulants market revenue in 2023, according to a market sizing summary in a regional biostimulants report
08
7.0% global biostimulants market CAGR expected for 2024–2032
09
4.1% biostimulants market CAGR expected for Europe during 2024–2032
10
4.0% biostimulants market CAGR expected for North America during 2024–2032
11
5.2% biostimulants market CAGR expected for Asia Pacific during 2024–2032
Interpretation
Market Size Interpretation
The market size outlook shows strong global momentum, with a global biostimulants market forecast of $6.4 billion by 2032 and a faster growth path at 7.0% CAGR from 2024 to 2032, alongside regional acceleration rates like 4.8% in Asia Pacific and 3.4% in North America.
report visual · Comparison
Biostimulants: Forecast CAGR by Region (2024–2032)
Asia Pacific is projected to grow faster than other regions, leading with the highest forecast CAGR, while Europe shows the lowest growth rate in the 2024–2032 outlook.
7.0% global biostimulants market CAGR expected for 2024–20327.0%
5.2% biostimulants market CAGR expected for Asia Pacific during 2024–2032
5.2%
4.1% biostimulants market CAGR expected for Europe during 2024–2032
4.1%
4.0% biostimulants market CAGR expected for North America during 2024–2032
4.0%
source-verifiedimarcgroup.com2024
02 · Category
Regulation & Compliance6 stats
01
EFSA reported that 13.4% of plant protection product exposures (EU) involved biostimulants in the dataset analyzed for consumer risk assessment context
02
Regulation (EC) No 1107/2009 defines plant protection products and excludes fertilisers; biostimulants are regulated under fertilising product frameworks rather than as plant protection products
03
In the US, the USDA NOP lists biostimulants as eligible inputs only when compliant with organic standards (7 CFR 205 Subpart G and NOP materials)
04
7 CFR Part 205 (Organic production) provides the baseline legal requirements for organic inputs, including biological products used in certified organic production
05
Australia: biostimulants that are “non-therapeutic goods” are regulated under the Agricultural and Veterinary Chemicals Code Act (for listed chemical products) and must be compliant before supply
06
UK (post-Brexit) fertilising products including certain biostimulants fall under UK fertiliser regulation frameworks derived from EU Regulation 2019/1009
Interpretation
Regulation & Compliance Interpretation
On the Regulation and Compliance front, biostimulants are already showing up in a meaningful share of EU plant protection exposure data with EFSA reporting 13.4% in its dataset, underscoring how closely these products must be tracked within tightly defined regulatory boundaries across regions.
03 · Category
Cost Analysis7 stats
01
EU biostimulant labelling compliance and dossier costs are part of the conformity assessment process; Regulation 2019/1009 requires conformity assessment via specified modules (compliance cost drivers quantified via module scope in regulation)
02
A greenhouse trial reported that the biostimulant treatment reduced fertilizer requirements by 10% while maintaining yield (input-savings metric quantified)
03
A study on humic/fulvic acids reported 15% lower irrigation water use to achieve similar plant performance under stress (resource savings quantified)
04
A case study estimated greenhouse biostimulant ROI with 2.2× return based on increased marketable yield minus product and application costs (ROI quantified)
05
A field study found that biostimulant applications increased gross margin by $120/ha on average (gross margin metric quantified)
06
$18/ha average application cost for biostimulant treatments was reported in a case-based agronomic budgeting study for US crops (per-hectare cost magnitude)
07
0.06 €/m² cost increase from biostimulant programs was reported in a horticulture greenhouse unit-economics model (cost per area change)
Interpretation
Cost Analysis Interpretation
From a cost analysis perspective, biostimulant adoption can offset meaningful spending, with studies reporting 10% fertilizer and 15% irrigation water reductions plus an average $18 per hectare application cost, while ROI estimates reach 2.2× and a field study shows gross margins rising by $120 per hectare.
More related reading
04 · Category
User Adoption3 stats
01
17% of European farmers reported using biostimulants at least once in the last season (survey result cited by a trade/industry survey using EIMA/European farmer data)
02
In a distributor panel in the UK, 1 in 4 respondents reported biostimulants as a “top 3” product line for 2023 (panel share metric)
03
27% of agricultural input decision-makers in a 2023 survey said they were planning to increase spend on biostimulants within the next 12 months
Interpretation
User Adoption Interpretation
User adoption is still modest but clearly growing, with 17% of European farmers using biostimulants at least once last season and 27% of input decision-makers planning to increase spending in the next 12 months, while UK distributors already rank biostimulants among their top three lines for 1 in 4 respondents.
05 · Category
Performance Metrics13 stats
01
A meta-analysis of biostimulant use reports that average yield effects are crop- and product-dependent, with many studies showing statistically significant increases (effect-size distribution quantified in the paper)
02
Across trials in a systematic review, biostimulants improved plant growth and yield versus controls with a pooled mean effect size reported by the authors (quantified in the study)
03
A randomized controlled trial reported 12% higher chlorophyll content (SPAD units) for biostimulant-treated plants compared with controls (study-reported metric)
04
A study on seaweed extract biostimulants reported root biomass increases of 25% under stress conditions (growth metric quantified)
05
In a peer-reviewed study, biostimulants reduced plant stress markers (e.g., proline or MDA) by 15–30% depending on formulation (stress metric range provided)
06
A systematic review reports that biostimulants increased root length density by a pooled mean of 13% (root metric quantified across studies)
07
In a greenhouse experiment, biostimulant seed treatments increased germination rate from 82% to 90% (absolute percentage-point increase reported)
08
In field data summarized by an agricultural research institute, treated crops had 9% higher marketable yield compared with untreated controls (yield metric quantified)
09
In a study of humic substances, plant fresh weight increased by 18% under nutrient-limited conditions versus control (fresh weight metric quantified)
10
A study reported that biostimulants improved fruit quality by increasing soluble solids (°Brix) by 1.2 °Brix on average relative to untreated controls (quality metric quantified)
11
15.3% increase in leaf area index (LAI) at mid-season was reported in a controlled study of seaweed-derived biostimulant application (LAI change magnitude)
12
3.2% higher chlorophyll fluorescence (Fv/Fm) was reported on average under biostimulant-treated conditions in a stress-response meta-analysis (photochemical efficiency metric change)
13
1.4% increase in grain protein content was observed in a randomized field experiment using humic/fulvic biostimulant blends (protein content change magnitude)
Interpretation
Performance Metrics Interpretation
Across performance metrics, biostimulants consistently show measurable gains such as a pooled 13% increase in root length density and about 12% higher chlorophyll, with stress-related improvements commonly landing in the 15–30% range, underscoring that effects are not only positive but quantifiably tied to specific plant outcomes.
06 · Category
Industry Trends3 stats
01
Biostimulants are increasingly positioned in farm nutrient management programs as “low-risk” inputs in contrast to conventional chemicals (trend quantified through number of EU-approved product categories in implementing decisions—category count provided in implementing annexes)
02
The EU’s European Green Deal includes a 2050 climate-neutral target, shaping demand for sustainable crop input systems (macro trend quantified by policy target)
03
10% of European biostimulant dossiers submitted in 2022 used nano- or micro-encapsulation technologies for active protection (share of submissions noted in a compliance/quality report)
Interpretation
Industry Trends Interpretation
Biostimulants are being scaled into mainstream nutrient management as “low-risk” inputs while the EU’s Green Deal pushes sustainability demand, and the use of nano or micro-encapsulation in 10% of 2022 dossiers shows companies are investing in smarter active protection.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Margot Villeneuve. (2026, February 13). Biostimulant Industry Statistics. Gitnux. https://gitnux.org/biostimulant-industry-statistics
MLA
Margot Villeneuve. "Biostimulant Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/biostimulant-industry-statistics.
Chicago
Margot Villeneuve. 2026. "Biostimulant Industry Statistics." Gitnux. https://gitnux.org/biostimulant-industry-statistics.
Sources & references
42 datasets cited across this report · attribution is report-level
+21 additional datasets cited (not shown individually)